Cargando…
Bioavailability of a dexlansoprazole delayed-release orally disintegrating tablet: effects of food and mode of administration
BACKGROUND: Dexlansoprazole is a proton pump inhibitor (PPI) approved for use in dual delayed-release capsule and orally disintegrating tablet (ODT) formulations. AIM: To assess effects of food, water, and route of administration on the bioavailability of dexlansoprazole 30-mg ODT. METHODS: Two sepa...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5323062/ https://www.ncbi.nlm.nih.gov/pubmed/28255251 http://dx.doi.org/10.2147/CEG.S121129 |